•
Mar 31, 2023

Immix Biopharma Q1 2023 Earnings Report

EPS
-$0.18
Previous year: -$0.1
+80.0%
Cash and Equivalents
$11.5M
Previous year: $19.1M
-39.9%
Total Assets
$13.2M
Previous year: $20M
-34.0%

Immix Biopharma

Immix Biopharma